APTOSE BIOSCIENCES INC.
Ownership & governance
Executives 3Avg age 59Avg tenure 6y
CP
C. Payne
Director of Finance/CFO
Age 63Since 2022-06-26Profile →
+2
Executives3
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| HANMI PHARM. CO., LTD. | 19.93 % | 508,710 |
| Andrew Schwartzberg | 7.105 % | 181,350 |
| DRW Securities LLC | 0.7742 % | 19,761 |
| William Rice | 0.2406 % | 6,140 |
| The Gleason Group, Inc. | 0.1648 % | 4,206 |
Catalog · 2026-07-09
Registry officers3
| Name | Role | Since | Shares |
|---|---|---|---|
| C. Payne | Director of Finance/CFO | 2022-06-26 | - |
| Rafael Bejar | Chief Tech/Sci/R&D Officer | 2019-12-31 | - |
| Victor Montalvo-Lugo | Chief Tech/Sci/R&D Officer | 2019-10-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Analyst consensus is temporarily unavailable.